Pharma serves as scapegoat for healthcare woes

Who's to blame for the U.S. healthcare industry's many problems? According to a new Harris Poll, some 84 percent of Americans say it's the pharmaceuticals industry, at least partly, with 53 percent saying pharma gets a "great deal" of the blame. Release

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.